G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 2, 2014, Pages 285-293

  Hamel, David ^a,b   Sanchez, Melanie ^c   Duhamel, François ^b   Roy, Olivier ^a,b   Honoré, Jean Claude ^a   Noueihed, Baraa ^c   Zhou, Tianwei ^a   Nadeau Vallée, Mathieu ^b   Hou, Xin ^a   Lavoie, Jean Claude ^a   Mitchell, Grant ^a   Mamer, Orval A ^d   Chemtob, Sylvain ^a,b,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

animals newborn; GPR91 protein mouse; hypoxia ischemia brain; intracellular signaling peptides and proteins; succinic acid

Indexed keywords

ANIMALS, NEWBORN; GPR91 PROTEIN, MOUSE; HYPOXIA-ISCHEMIA, BRAIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; SUCCINIC ACID;

ANGIOGENIC PROTEINS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL LINE; CEREBRAL CORTEX; CEREBRAL INFARCTION; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HYPOXIA-ISCHEMIA, BRAIN; INJECTIONS, INTRAVENTRICULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NEURONS; NEUROPROTECTIVE AGENTS; PROSTAGLANDIN ANTAGONISTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; SUCCINIC ACID; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 84895064386     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302131     Document Type: Article

References (64)

1. Cardenas JF, Rho JM, Kirton A. Pediatric stroke. Childs Nerv Syst. 2011;27:1375-1390
2. Sirinyan M, Sennlaub F, Dorfman A, Sapieha P, Gobeil F Jr, Hardy P, Lachapelle P, Chemtob S. Hyperoxic exposure leads to nitrative stress and ensuing microvascular degeneration and diminished brain mass and function in the immature subject. Stroke. 2006;37:2807-2815
3. Honoré JC, Kooli A, Hamel D, Alquier T, Rivera JC, Quiniou C, Hou X, Kermorvant-Duchemin E, Hardy P, Poitout V, Chemtob S. Fatty acid receptor Gpr40 mediates neuromicrovascular degeneration induced by transarachidonic acids in rodents. Arterioscler Thromb Vasc Biol. 2013;33:954-961
4. Ferriero DM. Neonatal brain injury. N Engl J Med. 2004;351:1985-1995
5. Buonocore G, Groenendaal F. Anti-oxidant strategies. Semin Fetal Neonatal Med. 2007;12:287-295
6. Liman TG, Endres M. New vessels after stroke: Postischemic neovascularization and regeneration. Cerebrovasc Dis. 2012;33:492-499
7. Thwaites JW, Reebye V, Mintz P, Levicar N, Habib N. Cellular replacement and regenerative medicine therapies in ischemic stroke. Regen Med. 2012;7:387-395
8. Dizon M, Szele F, Kessler JA. Hypoxia-ischemia induces an endogenous reparative response by local neural progenitors in the postnatal mouse telencephalon. Dev Neurosci. 2010;32:173-183
9. Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, Juul S, Back SA, Northington F, Robertson NJ, Mallard C, Gunn AJ. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol. 2012;71:589-600
10. Gonzalez FF, Larpthaveesarp A, McQuillen P, Derugin N, Wendland M, Spadafora R, Ferriero DM. Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke. Stroke. 2013;44:753-758
11. Komitova M, Mattsson B, Johansson BB, Eriksson PS. Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke. 2005;36:1278-1282
12. Cui X, Chopp M, Zacharek A, Dai J, Zhang C, Yan T, Ning R, Roberts C, Shehadah A, Kuzmin-Nichols N, Sanberg CD, Chen J. Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome. Neuroscience. 2012;227:223-231
13. Hoang S, Liauw J, Choi M, Choi M, Guzman RG, Steinberg GK. Netrin-4enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab. 2009;29:385-397
14. Mazighi M, Meseguer E, Labreuche J, Serfaty JM, Laissy JP, Lavallée PC, Cabrejo L, Guidoux C, Lapergue B, Klein IF, Olivot JM, Rouchaud A, Desilles JP, Schouman-Claeys E, Amarenco P. Dramatic recovery in acute ischemic stroke is associated with arterial recanalization grade and speed. Stroke. 2012;43:2998-3002
15. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest. 1999;79:417-425
16. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994;25:1794-1798
17. Lee HJ, Kim KS, Park IH, Kim SU. Human neural stem cells overexpressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One. 2007;2:e156
18. Jenkins DD, Chang E, Singh I. Neuroprotective interventions: Is it too late? J Child Neurol. 2009;24:1212-1219
19. Sahota P, Savitz SI. Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery. Neurotherapeutics. 2011;8:434-451
20. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: Evidence for a metabolic hypothesis. Am J Physiol. 1990;259(3 Pt2):R393-R404
21. Burns PA, Wilson DJ. Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF). Angiogenesis. 2003;6:73-77
22. Nawab ZM, Daugirdas JT, Ing TS, Leehey DJ, Reid RW, Klok MA. Calcium-complexing versus vasorelaxant effect of acetate, lactate, and other bases. Trans Am Soc Artif Intern Organs. 1984;30:184-188
23. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L. Citric acid cycle intermediates as ligands for orphan G-proteincoupled receptors. Nature. 2004;429:188-193
24. Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067-1076
25. Matsuda T, Abe T, Wu JL, Fujiki M, Kobayashi H. Hypoxia-inducible factor-1alpha DNA induced angiogenesis in a rat cerebral ischemia model. Neurol Res. 2005;27:503-508
26. Ndubuizu OI, Tsipis CP, Li A, LaManna JC. Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain. Brain Res. 2010;1366:101-109
27. Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005;4:3-8
28. Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PM, Milligan G. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int. 2009;76:1258-1267
29. Moreno-Manzano V, Rodríguez-Jiménez FJ, Aceña-Bonilla JL, Fustero-Lardíes S, Erceg S, Dopazo J, Montaner D, Stojkovic M, Sánchez-Puelles JM. FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status. J Biol Chem. 2010;285:1333-1342
30. Walker V, Pickard JD. Prostaglandins, thromboxane, leukotrienes and the cerebral circulation in health and disease. Adv Tech Stand Neurosurg. 1985;12:3-90
31. Barnett JM, McCollum GW, Penn JS. Role of cytosolic phospholipase A(2)in retinal neovascularization. Invest Ophthalmol Vis Sci. 2010;51:1136-1142
32. Xin X, Majumder M, Girish GV, Mohindra V, Maruyama T, Lala PK. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Lab Invest. 2012;92:1115-1128
33. Yanni SE, Barnett JM, Clark ML, Penn JS. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci. 2009;50:5479-5486
34. Yanni SE, Clark ML, Yang R, Bingaman DP, Penn JS. The effects of nepafenac and amfenac on retinal angiogenesis. Brain Res Bull. 2010;81:310-319
35. Zhang Y, Daaka Y. PGE2 promotes angiogenesis through EP4 and PKA Cgamma pathway. Blood. 2011;118:5355-5364
36. Spinella F, Rosanò L, Di Castro V, Natali PG, Bagnato A. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. J Biol Chem. 2004;279:46700-46705
37. Hatazawa R, Tanigami M, Izumi N, Kamei K, Tanaka A, Takeuchi K. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology. 2007;15:214-217
38. Leduc M, Hou X, Hamel D, et al. Restoration of renal function by a novel prostaglandin EP4 receptor-derived peptide in models of acute renal failure. Am J Physiol Regul Integr Comp Physiol. 2013;304:R10-R22
39. Kermorvant-Duchemin E, Sennlaub F, Sirinyan M, et al. Trans-Arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med. 2005;11:1339-1345
40. Honoré JC, Kooli A, Hou X, Hamel D, Rivera JC, Picard E, Hardy P, Tremblay S, Varma DR, Jankov RP, Mancini JA, Balazy M, Chemtob S. Sustained hypercapnia induces cerebral microvascular degeneration in the immature brain through induction of nitrative stress. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1522-R1530
41. Robertson PL, Du Bois M, Bowman PD, Goldstein GW. Angiogenesis in developing rat brain: An in vivo and in vitro study. Brain Res. 1985;355:219-223
42. Wang DB, Blocher NC, Spence ME, Rovainen CM, Woolsey TA. Development and remodeling of cerebral blood vessels and their flow in postnatal mice observed with in vivo videomicroscopy. J Cereb Blood Flow Metab. 1992;12:935-946
43. Cioni G, D'Acunto G, Guzzetta A. Perinatal brain damage in children: Neuroplasticity, early intervention, and molecular mechanisms of recovery. Prog Brain Res. 2011;189:139-154
44. Staudt M. Brain plasticity following early life brain injury: Insights from neuroimaging. Semin Perinatol. 2010;34:87-92
45. Madri JA. Modeling the neurovascular niche: Implications for recovery from CNS injury. J Physiol Pharmacol. 2009;60(suppl 4):95-104
46. Li WL, Yu SP, Ogle ME, Ding XS, Wei L. Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice. Dev Neurobiol. 2008;68:1474-1486
47. Risser L, Plouraboué F, Cloetens P, Fonta C. A 3D-investigation shows that angiogenesis in primate cerebral cortex mainly occurs at capillary level. Int J Dev Neurosci. 2009;27:185-196
48. Villa RF, Gorini A, Hoyer S. Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex. Neurochem Res. 2009;34:2102-2116
49. Pomytkin IA, Semenova NA. Study of the effect of preconditioning with succinic acid salt of choline (1:2) on the disturbances of energy metabolism in the brain during ischemia by 31P NMR in vivo. Dokl Biochem Biophys. 2005;403:289-292
50. Alessandri B. GM, Levasseur J., Bullock M.R. Lactate and glucose as energy substrates and their role in traumatic brain injury and therapy. Future Neurol. 2009;4:209-228
51. Horn T, Klein J. Neuroprotective effects of lactate in brain ischemia: Dependence on anesthetic drugs. Neurochem Int. 2013;62:251-257
52. Folbergrová J, Ljunggren B, Norberg K, Siesjö BK. Influence of complete ischemia on glycolytic metabolites, citric acid cycle intermediates, and associated amino acids in the rat cerebral cortex. Brain Res. 1974;80:265-279
53. Benzi G, Arrigoni E, Marzatico F, Villa RF. Influence of some biological pyrimidines on the succinate cycle during and after cerebral ischemia. Biochem Pharmacol. 1979;28:2545-2550
54. Manoonkitiwongsa PS, Jackson-Friedman C, McMillan PJ, Schultz RL, Lyden PD. Angiogenesis after stroke is correlated with increased numbers of macrophages: The clean-up hypothesis. J Cereb Blood Flow Metab. 2001;21:1223-1231
55. Ergul A, Alhusban A, Fagan SC. Angiogenesis: A harmonized target for recovery after stroke. Stroke. 2012;43:2270-2274
56. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998;58:362-366
57. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.Cell. 1995;83:493-501
58. Takemiya T, Matsumura K, Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem Int. 2007;51:112-120
59. Zheng Z, Yenari MA. Post-ischemic inflammation: Molecular mechanisms and therapeutic implications. Neurol Res. 2004;26:884-892
60. Nakanishi M, Sato T, Li Y, et al. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2receptor in cultured human lung fibroblasts. Am J Respir Cell Mol Biol. 2012;46:217-223
61. Liang X, Lin L, Woodling NS, Wang Q, Anacker C, Pan T, Merchant M, Andreasson K. Signaling via the prostaglandin E(2) receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. The Journal of clinical investigation. 2011;121:4362-4371
62. Smadja D. Pharmacological revascularization of acute ischaemic stroke: Focus on challenges and novel strategies. CNS Drugs. 2012;26:309-318
63. Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci. 2012;13:267-278
64. Liu R, Yuan H, Yuan F, Yang SH. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke. Neurol Res. 2012;34:331-337